Description: Fortress Biotech Inc is a biopharmaceutical company. The Company is engaged in the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer.
Home Page: www.fortressbiotech.com
FBIOP Technical Analysis
1111 Kane Concourse
Bay Harbor Islands,
FL
33154
United States
Phone:
781 652 4500
Officers
| Name | Title |
|---|---|
| Dr. Lindsay Allan Rosenwald | Exec. Chairman, Pres & CEO |
| Mr. Michael S. Weiss Esq. | Vice Chairman & Exec. Vice Chairman of Strategic Devel. |
| Dr. George C. Avgerinos | Sr. VP of Biologics Operations |
| Ms. Robyn M. Hunter | Exec. Officer |
| Mr. David Jin | CFO & Head of Corp. Devel. |
| Mr. Samuel Berry | Gen. Counsel & Corp. Sec. |
| Dr. Thomas F. Schaible | Project Leader of Inflammatory Bowel Disease |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.3576 |
| IPO Date: | 2017-11-14 |
| Fiscal Year End: | December |
| Full Time Employees: | 173 |